BeOne Medicines (ONC) Shareholder's Equity Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.03% |
| Dec 31, 2025 | 30.88% |
| Sep 30, 2025 | 20.18% |
| Jun 30, 2025 | 12.01% |
| Mar 31, 2025 | 4.14% |
| Dec 31, 2024 | -5.80% |
| Sep 30, 2024 | -8.69% |
| Jun 30, 2024 | -11.38% |
| Mar 31, 2024 | -19.17% |
| Dec 31, 2023 | -19.30% |
| Sep 30, 2023 | -19.16% |
| Jun 30, 2023 | -26.91% |
| Mar 31, 2023 | -28.00% |
| Dec 31, 2022 | -28.52% |
| Sep 30, 2022 | 38.67% |
| Jun 30, 2022 | 44.09% |
| Mar 31, 2022 | 44.22% |
| Dec 31, 2021 | 58.50% |
| Sep 30, 2021 | -21.70% |
| Jun 30, 2021 | 41.64% |
| Mar 31, 2021 | 41.62% |
| Dec 31, 2020 | 295.48% |
| Sep 30, 2020 | 231.28% |
| Jun 30, 2020 | 62.07% |
| Mar 31, 2020 | 74.22% |
| Dec 31, 2019 | -44.21% |
| Sep 30, 2019 | -34.75% |
| Jun 30, 2019 | 28.09% |
| Mar 31, 2019 | 19.43% |
| Dec 31, 2018 | 156.29% |
| Sep 30, 2018 | 164.41% |
| Jun 30, 2018 | 354.03% |
| Mar 31, 2018 | 340.55% |
| Dec 31, 2017 | 93.88% |
| Sep 30, 2017 | 299.37% |
| Jun 30, 2017 | 22.78% |
| Mar 31, 2017 | 26.87% |
| Dec 31, 2016 | 446.79% |